MedPath

Cyclosporine

Cyclosporine Injection, USP

Approved
Approval ID

5977b562-3624-427c-bc64-b07247751b9e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 1, 2023

Manufacturers
FDA

Padagis US LLC

DUNS: 967694121

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Cyclosporine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0574-0866
Application NumberANDA065151
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cyclosporine
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateOctober 1, 2023
FDA Product Classification

INGREDIENTS (4)

CYCLOSPORINEActive
Quantity: 50 mg in 1 mL
Code: 83HN0GTJ6D
Classification: ACTIB
POLYOXYL 35 CASTOR OILInactive
Code: 6D4M1DAL6O
Classification: IACT
ALCOHOLInactive
Code: 3K9958V90M
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Cyclosporine - FDA Drug Approval Details